Lupin Ltd. (LUPIN) Share Price Falls 3.43% as Large Cap Stock Clears Threshold

Lupin Ltd. fell to Rs 2,279, down 3.43% today, with market capitalisation at Rs 1,07,907.43 crore as the large-cap stock cleared its qualifying decline threshold.

Lupin Ltd. Share Price came under pressure on 10 August 2026, with the stock trading at Rs 2,279 at the time of this Univest update, down Rs 81 or 3.43% from the previous close of Rs 2,360. With a market capitalisation of Rs 1,07,907.43 crore, the move stands out because Lupin Ltd.

In today’s Stock Market Today and Share Market Today action, Lupin Ltd. Share Price moved from an opening level of Rs 2,360 to an intraday high of Rs 2,366.2 before sliding to a low of Rs 2,273.9. That intraday path shows that the session began near the previous close and then weakened through the day, placing the stock among the top decliner names being tracked in Stocks in News. The supplied data confirms the price event clearly, but it does not establish a company-specific catalyst behind the fall.

That matters for investors searching Lupin Ltd. Share Price Today, Lupin Ltd. Stock News, and Lupin Ltd. Share Price Fall because the move is not just a minor tick lower. It crossed the exact filter used for this event type, making it a verified market move worth monitoring. In a market where some counters may have participated in today’s rally elsewhere, Lupin Ltd. Share Price instead reflected selling pressure and weaker price action. Univest therefore examines the decline through price behaviour, company scale, sector benchmarks, peer positioning and business context rather than speculation.

Lupin Ltd. (LUPIN) Share Price Today: Price Action Analysis

Lupin Ltd. (LUPIN) traded at Rs 2,279. versus the previous close of Rs 2,360, a fall of 3.43%. The stock opened at Rs 2,360, reached Rs 2,366.2, touched Rs 2,273.9. Reported volume was 32,053.

Lupin Ltd. (LUPIN) Fundamental Analysis

Lupin Ltd. Fundamental Analysis, based strictly on the supplied data, begins with scale. The company’s market capitalisation is Rs 1,07,907.43 crore, which places it in a very different size bracket from most healthcare names included in the sector benchmark sample. Market cap does not describe quality by itself, but it does indicate that Lupin Ltd. is a large listed business whose stock movement can attract attention quickly when it appears in Top Losers Today or Stocks Falling Today screens.

This company size is especially notable against the broader Healthcare benchmark in the dataset. The benchmarkCompanyCount is 202, and within that same sector the median market capitalisation is Rs 130.8 crore while the average is Rs 460.68 crore. The benchmark market-cap range spans from Rs 2.09 crore at the minimum to Rs 3,032.97 crore at the maximum. Against those figures, Lupin Ltd. Share Price is attached to a company whose market capitalisation is far above the benchmark median, average and even the supplied maximum among benchmark companies. That does not say whether the stock is cheap or expensive, but it does underline the company’s scale and why a 3.43% move can command broader market attention.

For readers seeking Lupin Ltd. Stock Analysis, this means today’s weakness is occurring in a business that sits well above the size profile of many listed healthcare peers shown in the dataset. That can affect how traders, institutions and benchmark-aware investors frame price action, particularly on a day when the stock opened flat, tested Rs 2,366.2, and then fell toward Rs 2,273.9. At Univest, the key fundamental takeaway from the supplied figures is therefore not a valuation call, but the interaction between very large market capitalisation and a threshold-clearing one-day decline. That naturally leads into ownership structure where available and, in this case, into sector and peer context where the richest comparative data sits.

Sector and Industry Context

Lupin Ltd. (LUPIN) is classified under sector: Healthcare.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The sector data places Lupin Ltd. within Healthcare, and that benchmark offers important context for today’s share price decline. The supplied benchmark covers 202 companies in the same sector, giving investors a broad statistical frame for valuation, profitability and company size even when the immediate event is a single-day price fall.

The sectorSnapshot shows a Healthcare benchmarkScope of same sector with 202 companies. In valuation terms, the benchmark includes peCount of 157 companies, with a median P/E of 26.63, an average P/E of 92.4, and a wide range from 3.21 to 3,417.8. On price-to-book, pbCount is 201 with a median of 1.9, an average of 2.74, and a range from -22.33 to 59.75. Profitability also spans widely: roeCount is 201 with median ROE of 10.71 and average ROE of 14.58, while roceCount is 201 with median ROCE of 13.16 and average ROCE of 16.61.

Those benchmark numbers matter because they show how dispersed the Healthcare sector is. The range is broad across P/E, P/B, ROE and ROCE, which means investor positioning in healthcare is not centred on one uniform valuation template. Some companies in the space trade at low multiples, some at very high multiples, some generate negative returns on equity, and others show substantially stronger profitability. In that environment, a stock-specific price fall like the one seen in Lupin Ltd. Share Price Today can gain attention even without a supplied company catalyst, simply because healthcare is a diverse, actively screened sector in the Indian Stock Market.

The market-cap benchmark sharpens that picture further. marketCapCount is 202, the median is Rs 130.8 crore, the average is Rs 460.68 crore, the minimum is Rs 2.09 crore and the maximum is Rs 3,032.97 crore. Lupin Ltd.’s Rs 1,07,907.43 crore market capitalisation stands dramatically above those figures. So while the healthcare dataset is broad, Lupin Ltd. sits at a much larger scale than the benchmark population shown here. For Univest readers, that makes today’s decline notable not only as price action but also as a move in a very large healthcare name relative to the sector sample provided.

Peer Comparison

Lupin Ltd. (LUPIN) has a market capitalisation of Rs 1,07,907.43 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peers show that Lupin Ltd. is being viewed against a healthcare universe that is much smaller in market capitalisation and mixed in valuation and profitability. That comparison does not produce a recommendation, but it does help frame how unusual today’s move is in terms of company size and sector positioning.

The peerSnapshot includes names such as Dishman Carbogen Amcis Ltd. at Rs 3,032.97 crore market cap, Hikal Ltd. at Rs 2,799.54 crore, Kwality Pharmaceuticals Ltd. at Rs 2,707.2 crore, Beta Drugs Ltd. at Rs 2,631.45 crore, Dr Agarwals Eye Hospital Ltd. at Rs 2,537.93 crore, Panacea Biotec Ltd. at Rs 2,531.49 crore, Sai Parenteral’s Ltd. at Rs 2,513.58 crore, Solara Active Pharma Sciences Ltd. at Rs 2,422.79 crore, NGL Fine-Chem Ltd. at Rs 2,118.6 crore and Venus Remedies Ltd. at Rs 2,068.61 crore. On market cap alone, Lupin Ltd. at Rs 1,07,907.43 crore is far larger than every listed peer in this supplied set.

Among peers where P/E is available, Dishman Carbogen Amcis trades at 31.12, Kwality Pharmaceuticals at 40.2, Beta Drugs at 63.43, Dr Agarwals Eye Hospital at 33.3, Sai Parenteral’s at 176.28, NGL Fine-Chem at 44.02 and Venus Remedies at 17.81. P/B values range from 0.45 for Dishman Carbogen Amcis to 8.18 for Kwality Pharmaceuticals, with 6.27 for Beta Drugs and 6.43 for NGL Fine-Chem. Profitability is equally mixed: ROE is negative at Dishman Carbogen Amcis (-2.89) and Dr Agarwals Eye Hospital (-2.6), zero at Panacea Biotec, but higher at Kwality Pharmaceuticals (28.21), Beta Drugs (18.65) and NGL Fine-Chem (27.9). ROCE ranges from -0.26 at Dishman Carbogen Amcis to 33.91 at NGL Fine-Chem.

Because no company-specific valuation or profitability ratios for Lupin Ltd. are supplied in this dataset, the cleanest peer insight is one of relative scale and sector diversity. The company’s market capitalisation makes it structurally larger than the peer set, while the peer metrics show investors are comparing healthcare businesses across very different profitability and valuation profiles. That is why a 3.43% share price decline in Lupin Ltd. Share Price can become meaningful market news even without a verified catalyst attached.

Why Investors Are Watching Lupin Ltd.

Lupin Ltd. Share Price is drawing attention because the stock did not just fall in ordinary trade; it crossed the exact threshold for a Large Cap decline event. That makes it relevant for traders tracking price action, investors monitoring healthcare names, and readers following Lupin Ltd. Stock News and Market Movers across NSE News and BSE News.

• Verified price event: the stock fell 3.43% from Rs 2,360 to Rs 2,279, clearing the 3% Large Cap threshold.
• Intraday weakness: after opening at Rs 2,360 and touching Rs 2,366.2, the stock fell to Rs 2,273.9, showing sustained downward price action.
• Meaningful trading activity: totalVolume reached 13,17,125 shares, with NSE volume of 12,85,072 and BSE volume of 32,053.
• Large market scale: market capitalisation stands at Rs 1,07,907.43 crore, making it materially larger than the benchmark and supplied peers.
• Sector frame: the company sits in Healthcare, where benchmark valuation and profitability ranges are wide, keeping sector comparison relevant.

The next things investors may monitor are whether Lupin Ltd. Share Price stabilises closer to the day low of Rs 2,273.9 or reclaims levels nearer the open and previous close, how participation develops after total turnover of Rs 7.3 crore, and whether the stock continues to feature among Bearish Stocks, Stocks Under Pressure and wider Market News screens tracked by Univest.

About Lupin Ltd.

Lupin Ltd. is identified in the supplied data as part of the Healthcare sector. That sector classification alone places the company within one of the most closely watched groups in the Indian Stock Market, where investors often compare pharmaceutical, drug manufacturing and healthcare service businesses on valuation, profitability, scale and stock performance. In this article, the emphasis is on what the verified market data says about Lupin Ltd. Share Price rather than on unsupported corporate detail.

From a market perspective, the company stands out because of size. At Rs 1,07,907.43 crore in market capitalisation, Lupin Ltd. is far larger than the benchmark median of Rs 130.8 crore and benchmark average of Rs 460.68 crore within the supplied Healthcare dataset. It is also much larger than each of the listed peers included in the benchmarkCompanies and peerSnapshot arrays, which range from Rs 2,068.61 crore to Rs 3,032.97 crore.

That scale affects how the market reads the stock. A threshold-clearing fall in a very large healthcare company can influence screens such as Top Losers Today, Stocks in News and Stock Updates more visibly than similar moves in smaller counters. It also means Lupin Ltd. Share Price Today is likely to be followed not only by short-term traders looking at price action, but also by investors comparing sector breadth, peer dispersion and company size. At Univest, the company context from the supplied data is therefore simple but important: Lupin Ltd. is a major listed Healthcare name, and that alone gives today’s share price decline added market significance.

Track Lupin Ltd. Share Price on Univest

Use Lupin Ltd. (LUPIN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors following Lupin Ltd. Share Price can use Univest to track live share price moves, daily percentage changes, market capitalisation, 52-week levels, shareholding pattern, technical indicators where available and broader market insights in one place. For users searching Lupin Ltd. Share Price Today, Lupin Ltd. Stock News or Lupin Ltd. Share Price Update, the platform helps connect intraday price action with sector context, peer comparison and company-level market data.

On a day like this, when the stock falls 3.43% and qualifies for a threshold-based Large Cap decline event, that integrated view matters. Univest helps readers monitor whether the stock remains among top decliner names, how volumes evolve across NSE and BSE, and how the company compares with sector benchmarks and listed healthcare peers without turning the update into a recommendation.

Frequently Asked Questions

Why is Lupin Ltd. Share Price falling today?

Ans. The supplied data confirms that Lupin Ltd. Share Price fell 3.43% to Rs 2,279 from the previous close of Rs 2,360. It verifies the price event and threshold breach, but it does not establish any company-specific catalyst for the decline.

What is Lupin Ltd. Share Price Today?

Ans. Lupin Ltd. Share Price Today was Rs 2,279 at the time of the update. The stock was down Rs 81 or 3.43% on the day, after trading between an intraday high of Rs 2,366.2 and low of Rs 2,273.9.

How much did Lupin Ltd. stock fall from the previous close?

Ans. Lupin Ltd. stock declined by Rs 81 from the previous close of Rs 2,360 to Rs 2,279. In percentage terms, that was a 3.43% share price decline, which was large enough to trigger this Large Cap threshold-based event.

Why is this move important for a Large Cap stock?

Ans. The move matters because Lupin Ltd. Its one-day decline was 3.43%, so the stock entered a verified threshold screen rather than an ordinary daily loser.

What were the day’s open, high and low levels for Lupin Ltd.?

Ans. Lupin Ltd. opened at Rs 2,360, reached a day high of Rs 2,366.2 and fell to a day low of Rs 2,273.9. That pattern shows early stability near the previous close before the stock weakened through the session.

What does the volume data show for Lupin Ltd. today?

Ans. Total traded volume was 13,17,125 shares, made up of 12,85,072 shares on NSE and 32,053 shares on BSE. Turnover stood at Rs 7.3 crore, indicating that most exchange participation in the stock was concentrated on NSE.

What is Lupin Ltd.’s market capitalisation?

Ans. Lupin Ltd.’s market capitalisation was Rs 1,07,907.43 crore in the supplied data. That makes it much larger than the Healthcare benchmark median of Rs 130.8 crore and average of Rs 460.68 crore shown in this article.

Which sector does Lupin Ltd. belong to?

Ans. Lupin Ltd. belongs to the Healthcare sector in the supplied dataset. The benchmark covers 202 same-sector companies, giving investors context through median and average valuation, profitability and market-cap figures across a broad listed healthcare universe.

How does Lupin Ltd. compare with the supplied healthcare peers on size?

Ans. On market capitalisation, Lupin Ltd. is far larger than every supplied peer. The listed comparison set ranges from Rs 2,068.61 crore for Venus Remedies to Rs 3,032.97 crore for Dishman Carbogen Amcis, versus Lupin’s Rs 1,07,907.43 crore.

What should investors monitor next in Lupin Ltd. Share Price?

Ans. Investors may track whether Lupin Ltd. Share Price stabilises near the day low of Rs 2,273.9 or moves back toward the opening and previous close of Rs 2,360, while also watching volume participation and its position among top decliner screens.